CODEXIS INC revenue breakdown overview

CODEXIS INC revenue for the last year amounted to 59.06 M CHF, the most of which — 36.12 M CHF — came from its highest performing source at the moment, Biocatalysts, Pharmaceutical Intermediates, and Codex Biocatalyst Panels and Kits. The greatest contribution to the revenue figure was made by China — last year it brought CODEXIS INC 17.09 M CHF.